GHSI

Guardion Health Sciences, Inc. Common Stock

GHSI

Market cap $4.39M

Delisted

GHSI was delisted on the 11th of October, 2024.

Back to rankings

About: Guardion Health Sciences Inc clinical nutrition company that develops and distributes clinically supported dietary supplements and medical foods. It offers a portfolio of science-based, clinically supported products designed to support consumers, healthcare professionals and providers, and their patients by supporting bone health, eye health, cardiovascular health, and brain health through nutrients such as Calcium, Vitamin D, Vitamin K, Carotenoids, and Omega-3s.

Employees: 9

Healthcare Drug Manufacturers - General

Financial journalist opinion

Guardion Health Sciences Announces Declaration of Cash Distribution

HOUSTON, TEXAS, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) today announced that its Board of Directors declared a cash distribution (the “Distribution”) in an amount equal to $3.25 per share of common stock, par value $0.001 per share (the “Common Stock”), held by the Company's stockholders of record on October 30, 2024, which was the effective date of the Company's previously-announced legal dissolution. The Company expects to pay the Distribution on or before December 27, 2024.

Guardion Health Sciences Announces Declaration of Cash Distribution

Guardion Health Sciences Announces Filing of Certificate of Dissolution

HOUSTON, TEXAS, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”) today announced that it has filed a certificate of dissolution with the Secretary of State of the State of Delaware, which became effective upon filing on October 30, 2024 (the “Effective Date”). The filing of the certificate was made pursuant to the terms of the Company's Plan of Liquidation and Dissolution (the “Plan”) approved by stockholders at the Company's special meeting of stockholders held on May 31, 2024.

Guardion Health Sciences Announces Filing of Certificate of Dissolution

Guardion Health Sciences Declares Cash Dividend of $5.00 Per Share of Common Stock

HOUSTON, TEXAS, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”) today announced that its Board of Directors declared a cash dividend in an amount equal to $5.00 per share of common stock held by its stockholders of record on September 9, 2024 and a payment date of September 23, 2024.

Guardion Health Sciences Declares Cash Dividend of $5.00 Per Share of Common Stock

Guardion Health Sciences Announces Financial Results for the Three Months and Six Months Ended June 30, 2024

Guardion Also Provides an Update to Stockholders of Significant Recent Developments HOUSTON, TEXAS, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers science-based, clinically supported products designed for consumer ocular health, today announced its financial results for the three months and six months ended June 30, 2024, as described below. The Company also provided an update to stockholders of significant recent developments.

Guardion Health Sciences Announces Financial Results for the Three Months and Six Months Ended June 30, 2024

Guardion Health Sciences Announces Completion of Sale of its Viactiv® Brand and Business to Doctor's Best Inc. and Stockholder Approval of Plan of Liquidation and Dissolution

HOUSTON, TEXAS, May 31, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers a portfolio of science-based, clinically-supported products designed to support the health needs of consumers, healthcare professionals and providers and their patients, announced that today it closed on its Definitive Agreement to sell its Viactiv business to Doctor's Best Inc. for gross cash consideration of $17,200,000. The Company received net cash proceeds of $16,250,000 at closing, with another $225,000 retained in a third-party escrow account with U.S. Bank, NA, to be released in accordance with the terms of the transaction documents.

Guardion Health Sciences Announces Approval by Stockholders of Proposed Sale of Viactiv Business

Adjourns Special Meeting to May 31, 2024 in order to Solicit Additional Proxies in Support of its Plan of Liquidation and Dissolution

Guardion Health Sciences Announces Approval by Stockholders of Proposed Sale of Viactiv Business

Guardion Health Sciences Announces

-- Financial Results for the Three Months Ended March 31, 2024 -- Institutional Shareholder Services Issues Report Recommending that Institutional Stockholders Vote in Favor of All Proposals at the Upcoming Special Meeting of Stockholders on May 23, 2024 Board of Directors Urges Stockholders to Vote to Approve the Sale of the Company's Viactiv Brand and Business and Plan of Liquidation and Dissolution If both proposals are approved, stockholders would receive one or more liquidating cash distributions, which combined are expected to represent a premium over our recent stock price HOUSTON, TEXAS, May 13, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers a portfolio of science-based, clinically-supported products designed to support the health needs of consumers, healthcare professionals and providers and their patients, announced its financial results for the three months ended March 31, 2024, as described below. The Company is also providing an update regarding proposals to be considered at its upcoming Special Meeting of Stockholders.

Guardion Health Sciences Announces

Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2023

Viactiv ® Product Line Generated Net Revenues of Approximately $11.9 Million for the Year Ended December 31, 2023, an Increase of Approximately 12% as Compared to the Year Ended December 31, 2022

Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2023

Why Is Guardion Health (GHSI) Stock Up 66% Today?

Guardion Health Sciences (NASDAQ: GHSI ) stock is rocketing higher on Wednesday after the company announced an agreement to sell its Activ Nutritional subsidiary. Doctor's Best is acting as the buyer of Activ Nutritional and that includes the Viactiv brand and business.

What made Guardion Health stock double on Wednesday?

Guardion Health Sciences Inc (NASDAQ: GHSI) is up nearly 100% this morning after Doctor's Best Inc agreed to buy its Activ Nutritional LLC. Could Guardion Health stock climb any further?

See News Rankings

Charts implemented using Lightweight Charts™